EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma

Lounes Djerroudi, Amel Bendali, Laetitia Fuhrmann, Camille Benoist, Gaelle Pierron, Julien Masliah-Planchon, Yann Kieffer, Matthieu Carton, Jean-Christophe Tille, Joanna Cyrta, Toulsie Ramtohul, Claire Bonneau und 5 weitere

Modern Pathology · 2024-10 · 37 (10) · 100570

DOI: 10.1016/j.modpat.2024.100570 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2024-10. Verfasst von Lounes Djerroudi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France; Institut Curie, Women's C…. Hauptthemen laut MEDLINE: Cadherins, Carcinoma, Lobular, Breast Neoplasms, Mutation. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Invasive lobular carcinomas (ILC) are characterized by the loss of E-cadherin expression and CDH1 gene inactivation. Diagnostic reproducibility for this tumor type is currently suboptimal and could be improved by a better understanding of its histomolecular and clinical heterogeneity. We have analyzed the relationship between the presence, type, or position of CDH1 mutations, E-cadherin expression, and clinicopathological features (including outcome) in a retrospective series of 251 primary ILC with a long follow-up (median: 9.5 years). The mutational status of E-cadherin gene (CDH1) was determined by RNA sequencing from frozen tumor samples. E-cadherin immunohistochemistry (IHC) was performed with antibodies directed against the intracellular domain (clone 4A2C7) and the extracellular domain (clone NCH38). IHC expression of p120 and β-catenin was also assessed in E-cadherin diffusely positive cases. Three major patterns of E-cadherin membrane expression were identified by IHC, with good agreement between the 2 clones (overall concordance: 83.8%, Kappa 0.67): null/focal expression (≤10%) (72.8% of cases for 4A2C7 and 83.8% for NCH38), heterogeneous expression (11%-89%) (19.2% of cases for 4A2C7 and 6.9% for NCH38), and diffuse expression (≥90%) (8% of cases for 4A2C7 and 9.3% for NCH38). E-cadherin membranous expression, when present, was abnormal (incomplete labeling and/or reduced intensity). ILC with diffuse E-cadherin expression showed abnormal β-catenin or p120-catenin staining in 21% of cases. Interestingly, these cases with diffusely expressed E-cadherin had a CDH1 mutation rate as high as the E-cadherin null/focal cases (∼70%) but were enriched in nontruncating mutations. Regarding CDH1 mutation location, intracytoplasmic domain mutations correlated with a divergent E-cadherin IHC phenotype between the 2 antibodies (4A2C7 ≤ 10%/NCH38 ≥ 10%). Clinico-pathological correlation analyses found that stromal amount (inversely correlated with tumor cellularity) and tumor-infiltrating lymphocytes were less abundant in ILC with E-cadherin null/focal cases. In addition, CDH1 truncating mutations were associated with radiohistologic size discordance and were identified in multivariate survival analysis as an independent poor prognosis factor in terms of metastasis risk and breast cancer-related mortality. Overall, our study highlights the importance of the precise mutational status of CDH1 in the clinical, radiological, histologic, and phenotypic expression of lobular carcinomas. These findings should be taken into account in future attempts to improve diagnostic criteria or methods for ILC, as well as for clinicobiological studies dedicated to this tumor type.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CadherinsCarcinoma, LobularBreast NeoplasmsMutationAntigens, CDBiomarkers, TumorHumansFemaleMiddle AgedAgedRetrospective StudiesAdultAged, 80 and overImmunohistochemistry

Stichwörter der Autor:innen

CDH1 mutationsE-cadherin immunohistochemistryinvasive lobular carcinomaprognosis

Substanzen

CadherinsCDH1 protein, humanAntigens, CDBiomarkers, Tumor

Autor:innen und Institutionen

  • Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France; Institut Curie, Women's Cancer Institute, PSL University, INSERM U830, Stress and Cancer Labora…
  • Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France.
  • Institut Curie, Women's Cancer Institute, PSL University, Clinical Bioinformatics, Paris, France.
  • Institut Curie, Women's Cancer Institute, PSL University, INSERM U830, Stress and Cancer Laboratory, Paris, France.
  • Institut Curie, PSL University, Department of Statistics, Paris, France.
  • Institut Curie, Women's Cancer Institute, PSL University, Department of Diagnostic and Theranostic Medicine, Paris, France; Hopitaux Universitaires de Geneve, Department of Pathology, Geneva, Switzerland.

Zitieren

APA

Djerroudi, L., Bendali, A., Fuhrmann, L., Benoist, C., Pierron, G., Masliah-Planchon, J., Kieffer, Y., Carton, M., Tille, J. C., Cyrta, J., Ramtohul, T., Bonneau, C., Caly, M., Renault, V., Bidard, F. C., Mechta-Grigoriou, F., & Vincent-Salomon, A. (2024). E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma. Modern Pathology, 37(10), 100570. https://doi.org/10.1016/j.modpat.2024.100570

Vancouver

Djerroudi L, Bendali A, Fuhrmann L, Benoist C, Pierron G, Masliah-Planchon J, et al. E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma. Modern Pathology. 2024;37(10):100570. doi:10.1016/j.modpat.2024.100570

BibTeX
@article{Djerroudi2024,
  author = {Djerroudi, Lounes and Bendali, Amel and Fuhrmann, Laetitia and Benoist, Camille and Pierron, Gaelle and Masliah-Planchon, Julien and Kieffer, Yann and Carton, Matthieu and Tille, Jean-Christophe and Cyrta, Joanna and Ramtohul, Toulsie and Bonneau, Claire and Caly, Martial and Renault, Victor and Bidard, François-Clément and Mechta-Grigoriou, Fatima and Vincent-Salomon, Anne},
  title = {E-Cadherin Mutational Landscape and Outcomes in Breast Invasive Lobular Carcinoma},
  journal = {Modern Pathology},
  year = {2024},
  volume = {37},
  number = {10},
  pages = {100570},
  doi = {10.1016/j.modpat.2024.100570}
}
Kostenlos starten →